Clinical Trial Update: Vitamin E Pharmacokinetics and Biomarkers in Normal and Obese Women [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic study evaluating vitamin E (tocopherol) absorption and biomarkers in normal-weight and obese women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Nonalcoholic Fatty Liver Disease
• Obesity

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Diabetes, Fatty Liver | Phase 1 | Status: COMPLETED